GeneCopoeia Revenue and Competitors
Estimated Revenue & Valuation
- GeneCopoeia's estimated annual revenue is currently $1.9M per year.
- GeneCopoeia's estimated revenue per employee is $155,000
Employee Data
- GeneCopoeia has 12 Employees.
- GeneCopoeia grew their employee count by 9% last year.
GeneCopoeia's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & President | Reveal Email/Phone |
2 | Technical Support Specialist | Reveal Email/Phone |
3 | Technical administrative specialist | Reveal Email/Phone |
GeneCopoeia Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is GeneCopoeia?
GeneCopoeia, Inc. is a leading provider and manufacture of genomics and proteomics products and services worldwide. GeneCopoeia has developed a series of cutting edge research tools, including the largest collection of expression-ready clones (ORF cDNA, Promoter, shRNA, miRNA), comprehensive genome-editing tools (CRISPR and TALEN), as well as highly efficient viral delivery systems (Lentivirus and AAV). In addition to its genomics and proteomics products, GeneCopoeia also offers fluorescent detection reagents (e.g. non-toxic DNA gel stains, protein gel stains, cell biology assay kits, labeling dyes and antibodies), as well as other molecular biology reagents and kits (e.g. luciferase assay kits, qPCR arrays and products, transfection reagents and more).
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | 0% | N/A |
#2 | $1M | 12 | N/A | N/A |
#3 | $1M | 12 | -29% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1.9M | 12 | -8% | N/A |